SLBP Inhibitors
SLBP inhibitors belong to a distinctive chemical class that plays a pivotal role in regulating key cellular processes associated with mRNA metabolism. SLBP, or Stem-Loop Binding Protein, is a critical protein involved in the processing of histone mRNA, a specialized class of messenger RNA responsible for encoding histone proteins. Histones, essential components of chromatin, play a fundamental role in packaging and organizing DNA within the nucleus. The unique structure of SLBP Inhibitors allows them to interact selectively with the Stem-Loop Binding Protein, modulating its activity and subsequently influencing histone mRNA processing.
The mechanism of action of SLBP Inhibitors hinges on their ability to disrupt the binding between SLBP and the stem-loop structure present in histone mRNA. This interaction is vital for the stability and translation of histone mRNA. By interfering with this process, SLBP Inhibitors introduce a regulatory layer in the intricate machinery of gene expression, potentially influencing cellular functions such as DNA replication, repair, and chromatin remodeling. The development of these inhibitors reflects a deeper understanding of the molecular intricacies governing mRNA processing and highlights the significance of SLBP as a potential target for fine-tuning cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that can disrupt various transcription factors, potentially affecting SLBP mRNA levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that could stabilize SLBP by preventing its proteasomal degradation. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits nuclear export by blocking the CRM1/exportin 1 pathway, potentially increasing the nuclear retention of SLBP. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, which could indirectly affect SLBP levels and its associated functions. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, which may decrease SLBP mRNA synthesis indirectly. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is another proteasome inhibitor that could prevent the degradation of SLBP, maintaining its cellular levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can affect protein synthesis and potentially influence SLBP expression levels. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a CDK inhibitor that may disrupt cell cycle progression, indirectly influencing SLBP function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which can affect various cellular processes, including those that involve SLBP. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Olomoucine is another CDK inhibitor that could affect cell cycle-related processes and thereby indirectly influence SLBP levels. | ||||||